Corona Remedies announces IPO opening on 8 December 2025
Price band set at ₹1,008–₹1,062 per equity share
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Cipla launches Ciplostem cell therapy for Knee Osteoarthritis in India
DCGI approval marks Cipla’s entry into orthobiologic medicine
Merck announces winners of the Merck Young Scientist Award 2025
Fourth edition recognises researchers across chemical and biological sciences categories
Green Pharma: How the industry can reduce its carbon footprint without compromising growth
Dr Supriya Shidhaye outlines how the pharma industry can shrink emissions while maintaining output and market expansion
SPARC wins U.S. court ruling on Sezaby Priority Review Voucher
U.S. District Court grants summary judgment in SPARC’s favour on Sezaby-linked voucher
Innovation made in India
As the world closes its doors and builds walls, India can chart its own course by leading the next wave of affordable, accessible…
Biocon Biologics reaches settlement with Amgen for Denosumab biosimilars commercialisation
Agreement enables Europe launch of Vevzuo and Evfraxy from December 2025
SAI Parenterals acquires 74.6% stake in Noumed Pharmaceuticals for INR 125 crore
Acquisition announced as SAI Parenterals files IPO DRHP with SEBI
Granules India inaugurates two Centres of Excellence at IIT Hyderabad
The Centres were inaugurated at the Institute’s Technology Research Park
Telangana launches Telangana 1 Bio to support biologics scale-up and innovation
Government inaugurates India’s first single-use bioprocess design and scale-up facility at Genome Valley during its 25-year…